Eli Lilly’s new Lilly Employer Connect platform offers employers more flexible access to obesity drugs like Zepbound, but experts say it represents only incremental progress.
The post Lilly Employer Connect Adds Flexibility for Employers But Isn’t Revolutionary, Expert Says appeared first on MedCity News.
